CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (10,001,089)	$ (9,760,903)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	486,786	557,968
Stock-based compensation expense	2,562,300	1,444,170
Loss on sale of property, plant and equipment		5,520
Common stock issued for consulting services		78,134
Provision for bad debts	368,168	106,247
Change in operating assets and liabilities:
Accounts receivable	1,576,636	170,962
Inventories	(78,761)	(136,783)
Prepaid expenses and other current assets and deposits	86,272	107,343
Accounts payable and accrued liabilities	(418,689)	(589,705)
Deferred revenue	(1,146,903)	566,732
Net cash used in operating activities	(6,565,280)	(7,450,315)
Cash flows used in investing activities:
Proceeds from sale of property, plant and equipment		5,500
Purchase of property, plant and equipment	(111,312)	(594,808)
Purchase of intangible assets		(43,353)
Net cash used in investing activities	(111,312)	(632,661)
Cash flows from financing activities:
Net proceeds from sale of common stock and warrants	4,600,127	7,853,155
Proceeds from the exercise of warrants		4,410
Net cash provided by financing activities	4,600,127	7,857,565
Net decrease in cash and cash equivalents	(2,076,465)	(225,411)
Cash and cash equivalents at beginning of period	4,479,274	7,312,184
Cash and cash equivalents at end of period	2,402,809	7,086,773
Supplemental Disclosures of Cash Flow Information:
Cash paid during period for interest
Cash paid during period for income taxes
Non-cash investing and financing activities:
Common stock issued in exchange for subscriptions receivable	1,505,000
Reclassification of deferred offering costs to additional paid-in capital	$ 13,986
Intangible assets acquired, and included in accounts payable		$ 60,468